Personalized medicine and the genotype–phenotype dilemma
- 183 Downloads
Important human phenotypes like height or facial appearance run in families—that has been known for millennia. Systematic studies of the way in which crossing pea plants resulted in changes in important pea plant phenotypes such as flower color or leaf number were defined in the mid-nineteenth century by Mendel  and the chemical basis for “inherited inborn errors of metabolism” by Garrod  at the turn of the twentieth century. Thus, some of the fundamental and familiar rules that we accept in a contemporary understanding of human genetics were laid down decades ago. However, an understanding of the mechanisms whereby genetic information is transmitted from generation to generation and how this information modulates important physiologic or disease susceptibility traits has been more recent. The fundamental discovery was the double-helix structure of DNA, which immediately led to the inference that DNA replication might replicate itself . The last 50 years has seen the...
KeywordsPhenotypes Genotypes DNA
This study was supported in part by grants from the US National Institutes of Health (U01 HL65962, RC2 GM092618, U01 HG04603).
Conflicts of interest
Dr. Roden is a consultant to Sanofi-Aventis, one of the sponsors of the meeting at which this work was presented. Dr. Roden retained full control of this manuscript throughout its generation; as this is a review, there are no primary data.
- 1.Mendel, G. (1866). Experiments in plant hybridization. Verhandlungen des naturforschenden Vereines in Brunn, bd IV fur das Jahr 1865, Abhandlungen, pp 3–47.Google Scholar
- 2.Garrod, A. E. (1923). Inborn errors of metabolism (2nd ed.). Oxford: Oxford University Press.Google Scholar
- 5.Romano, C., Gemme, G., & Pongiglione, R. (1963). Aritmie cardiache rare in età pediatrica. Clinical Pediatrics, 45, 656–683.Google Scholar
- 6.Ward, O. C. (1964). A new familial cardiac syndrome in children. J Irish Med Assoc, 54, 103–106.Google Scholar
- 25.Wang, J., Klysik, E., Sood, S., Johnson, R. L., Wehrens, X. H., & Martin, J. F. (2010). Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proceedings of the National Academy of Sciences of the United States of America, 107, 9753–9758.PubMedCrossRefGoogle Scholar
- 30.Rowan, S. B., Estrada, J. C., Stubblefield, T., Kucera, G., Carter, S., Roden, D. M., et al. (2009). A single nucleotide polymorphism at 4q25 associated with atrial fibrillation modulates symptomatic response to antiarrhythmic drug therapy. Heart Rhythm, 6, PO04-7.Google Scholar
- 37.Denny, J. C., Ritchie, M. D., Crawford, D. C., Schildcrout, J. S., Ramirez, A. H., Pulley, J. M., et al. (2010). Identification of genomic predictors of atrioventricular conduction: Using electronic medical records as a tool for genome science. Circulation, 122, 2016–2021.PubMedCrossRefGoogle Scholar
- 40.Shuldiner, A. R., O'Connell, J. R., Bliden, K. P., Gandhi, A., Ryan, K., Horenstein, R. B., et al. (2009). Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. Journal of the American Medical Association, 302, 849–857.PubMedCrossRefGoogle Scholar
- 41.Veenstra, D. L., You, J. H., Rieder, M. J., Farin, F. M., Wilkerson, H. W., Blough, D. K., et al. (2005). Association of vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Pharmacogenetics and Genomics, 15, 687–691.PubMedCrossRefGoogle Scholar
- 51.Dekker, L. R. C., Bezzina, C. R., Henriques, J. P. S., Tanck, M. W., Koch, K. T., Alings, M. W., et al. (2006). Familial sudden death is an important risk factor for primary ventricular fibrillation: A case–control study in acute myocardial infarction patients. Circulation, 114, 1140–1145.PubMedCrossRefGoogle Scholar